174 related articles for article (PubMed ID: 22261546)
1. Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis.
Foster M; Zivadinov R; Weinstock-Guttman B; Tamaño-Blanco M; Badgett D; Carl E; Ramanathan M
J Neuroimmunol; 2012 Feb; 243(1-2):61-8. PubMed ID: 22261546
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
3. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
[TBL] [Abstract][Full Text] [Related]
4. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
Sanfilipo MP; Benedict RH; Sharma J; Weinstock-Guttman B; Bakshi R
Neuroimage; 2005 Jul; 26(4):1068-77. PubMed ID: 15961046
[TBL] [Abstract][Full Text] [Related]
5. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
6. Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
Minneboo A; Uitdehaag BM; Jongen P; Vrenken H; Knol Dl; van Walderveen MA; Polman CH; Castelijns JA; Barkhof F
Mult Scler; 2009 May; 15(5):632-7. PubMed ID: 19389751
[TBL] [Abstract][Full Text] [Related]
7. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
[TBL] [Abstract][Full Text] [Related]
8. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
10. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
[TBL] [Abstract][Full Text] [Related]
11. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
[TBL] [Abstract][Full Text] [Related]
12. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.
Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK
Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474
[TBL] [Abstract][Full Text] [Related]
13. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis.
Zivadinov R; Uxa L; Zacchi T; Nasuelli D; Ukmar M; Furlan C; Pozzi-Mucelli R; Tommasi MA; Locatelli L; Ulivi S; Bratina A; Bosco A; Grop A; Cazzato G; Zorzon M
J Neurol; 2003 Sep; 250(9):1099-106. PubMed ID: 14504973
[TBL] [Abstract][Full Text] [Related]
14. The effect of alcohol and red wine consumption on clinical and MRI outcomes in multiple sclerosis.
Diaz-Cruz C; Chua AS; Malik MT; Kaplan T; Glanz BI; Egorova S; Guttmann CRG; Bakshi R; Weiner HL; Healy BC; Chitnis T
Mult Scler Relat Disord; 2017 Oct; 17():47-53. PubMed ID: 29055473
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
[TBL] [Abstract][Full Text] [Related]
16. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
Calabrese M; De Stefano N; Atzori M; Bernardi V; Mattisi I; Barachino L; Morra A; Rinaldi L; Romualdi C; Perini P; Battistin L; Gallo P
Arch Neurol; 2007 Oct; 64(10):1416-22. PubMed ID: 17923625
[TBL] [Abstract][Full Text] [Related]
17. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
18. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.
Zivadinov R; Weinstock-Guttman B; Benedict R; Tamaño-Blanco M; Hussein S; Abdelrahman N; Durfee J; Ramanathan M
Hum Mol Genet; 2007 Nov; 16(22):2659-68. PubMed ID: 17656372
[TBL] [Abstract][Full Text] [Related]
19. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
[TBL] [Abstract][Full Text] [Related]
20. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.
Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D
Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]